Your session is about to expire
← Back to Search
experimental for Prophylaxis of Skin Infections
Phase 2
Waitlist Available
Research Sponsored by CareFusion
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 min
Awards & highlights
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of a topical antiseptic for preoperative skin preparation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 min
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 min
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percentage of Abdominal Site Responder Rates at 10 Minutes
Percentage of Abdominal Site Responder Rates at 6 Hours
Percentage of Groin Site Responder Rate at 6 Hours
+1 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: experimentalExperimental Treatment1 Intervention
BDIP-0001
Group II: comparatorActive Control1 Intervention
Chlorhexidine gluconate
Group III: placeboPlacebo Group1 Intervention
Vehicle
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
N,N'-(1,10-decanediyldi-1(4H)-Pyridinyl-4-ylidene)-Bis-(1-octanamine) Dihydrochloride
2016
Completed Phase 2
~150
Find a Location
Who is running the clinical trial?
CareFusionLead Sponsor
17 Previous Clinical Trials
19,374 Total Patients Enrolled
Kevin BurroughsStudy DirectorBecton, Dickinson and Company
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger